Related Experiment Videos
Metabolomic differences in heart failure patients with and without major depression
David C Steffens1, Wei Jiang, K Ranga R Krishnan
1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. steff001@mc.duke.edu
Journal of Geriatric Psychiatry and Neurology
|January 27, 2010
Summary
Depressed patients with heart failure showed distinct metabolic profiles, including elevated amino acids and fatty acids, compared to non-depressed individuals. This study used metabolomics to identify these key biochemical differences in depression.
Area of Science:
- Biochemistry
- Clinical Medicine
- Metabolomics
Background:
- Metabolomics enables the comprehensive analysis of small molecules within biological systems.
- Depression is a significant health concern, and its metabolic underpinnings require further elucidation.
- Understanding metabolic differences in depression is crucial for developing targeted interventions.
Purpose of the Study:
- To investigate and identify specific metabolic differences between depressed and non-depressed individuals with heart failure.
- To characterize the plasma metabolome in relation to depressive state within a heart failure cohort.
Main Methods:
- Plasma samples were collected from depressed heart failure patients and a non-depressed heart failure comparator group.
- Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were employed for metabolomic profiling.
- Statistical analysis was performed to identify significant biochemical differences between the study groups.
Main Results:
- Significant differences in biochemical concentrations were observed between depressed and non-depressed participants.
- Depressed individuals exhibited higher levels of certain amino acids and dicarboxylic fatty acids.
- These findings align with previous research linking neurotransmitter and fatty acid metabolism to depression.
Conclusions:
- Metabolomic analysis reveals distinct biochemical profiles associated with depression in heart failure patients.
- Elevated amino acids and dicarboxylic fatty acids may serve as potential biomarkers for depression in this population.
- Further research is needed to clarify the influence of heart failure on these observed metabolic alterations.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...